{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:28:05Z","timestamp":1762507685673,"version":"3.40.5"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"vor","delay-in-days":66,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.idcr.2019.e00518","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T11:59:46Z","timestamp":1553342386000},"page":"e00518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Disseminated tuberculosis and hemophagocytic syndrome although TB prophylaxis in patients with inflammatory bowel disease treated with Infliximab"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-7960","authenticated-orcid":false,"given":"Modesto","family":"Mart\u00ednez-Pillado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Varela-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Said-Criado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"D\u00edaz-Parada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Rodr\u00edguez-Losada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Mendoza-Pintos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"July (07)","key":"10.1016\/j.idcr.2019.e00518_bib0005","first-page":"395","article-title":"Situaci\u00f3n actual de la tuberculosis en Espa\u00f1a: incidencia y mortalidad desde 1995","volume":"28","author":"Rodr\u00edguez Val\u00edn","year":"2002","journal-title":"Caracter\u00edsticas de los casos de tuberculosis y meningitis tuberculosa declarados en 2000"},{"issue":"July (7)","key":"10.1016\/j.idcr.2019.e00518_bib0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ajg.2013.144","article-title":"Reactivation of latent tuberculosis in a Crohn\u2019s patient after TB prophylaxis treated with adalimumab","volume":"108","author":"Caldera","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"April (4)","key":"10.1016\/j.idcr.2019.e00518_bib0015","article-title":"Different risk of tuberculosis and efficacy of isoniazid prophylaxis in rheumatoid arthritis patients with biologic therapy: a nationwide retrospective cohort study in Taiwan","volume":"11","author":"Liao","year":"2016","journal-title":"PLoS One"},{"issue":"September (8)","key":"10.1016\/j.idcr.2019.e00518_bib0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.medcli.2010.11.016","article-title":"Hemophagocytic syndrome associated with disseminated tuberculosis","volume":"137","author":"Becker","year":"2011","journal-title":"Med Clin (Barc)"},{"issue":"July (7)","key":"10.1016\/j.idcr.2019.e00518_bib0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1473-3099(06)70524-2","article-title":"Tuberculosis-associated haemophagocytic syndrome","volume":"6","author":"Brastianos","year":"2006","journal-title":"Lancet Infect Dis"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250918301306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250918301306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:06:56Z","timestamp":1556795216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250918301306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":5,"alternative-id":["S2214250918301306"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2019.e00518","relation":{},"ISSN":["2214-2509"],"issn-type":[{"type":"print","value":"2214-2509"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disseminated tuberculosis and hemophagocytic syndrome although TB prophylaxis in patients with inflammatory bowel disease treated with Infliximab","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2019.e00518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e00518"}}